(Q42981952)
Statements
1 reference
Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer (English)
1 reference
Bradley J Monk
1 reference
Luis Mas Lopez
1 reference
Juan J Zarba
1 reference
Ana Oaknin
1 reference
Carole Tarpin
1 reference
Wichai Termrungruanglert
1 reference
Jacquelyn A Alber
1 reference
Jie Ding
1 reference
Melissa W Stutts
1 reference
Lini N Pandite
1 reference
6 July 2010
1 reference
1 reference
28
1 reference
22
1 reference
3562-3569
1 reference
Identifiers
1 reference
1 reference